E. Nishimoto

Title The RECK tumor-suppressor protein binds and stabilizesADAMTS 10

H. Kitayama, D. Alexander, M. Noda, 2019 .

The RECK tumor-suppressor protein binds and stabilizes ADAMTS10

H. Kitayama, D. Alexander, M. Noda, 2018, Biology Open.

Reversion‐inducing cysteine‐rich protein with Kazal motifs and MT1‐MMP promote the formation of robust fibrillin fibers

D. Keene, M. Noda, T. Matsuzaki, 2020, Journal of cellular physiology.

A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs

H. Kitayama, M. Hiraoka, M. Uesugi, 2010, Oncotarget.

Novel RAF/MEK inhibitor CH5126766/VS‐6766 has efficacy in combination with eribulin for the treatment of triple‐negative breast cancer

M. Horinaka, T. Sakai, E. Konishi, 2021, Cancer Science.

The histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth of triple-negative breast cancer cells with the suppression of survivin, Bcl-xL, and the MAPK pathway

M. Horinaka, T. Sakai, T. Taguchi, 2018, Breast Cancer Research and Treatment.

Salicylic acid directly binds to ribosomal protein S3 and suppresses CDK4 expression in colorectal cancer cells.

M. Horinaka, Toshiyuki Sakai, M. Mutoh, 2022, Biochemical and biophysical research communications.

Discovery of cancer-preventive juices reactivating RB functions

M. Horinaka, Toshiyuki Sakai, M. Mutoh, 2023, Environmental health and preventive medicine.